ArticleFrontiers in immunology2025

Dual function antibody targeting αvβ3 and PD-L1 provide a promising strategy for solid tumor therapy.

Guixia Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.